PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
PCT/2000/42 : PCT Gazette, Weekly Issue No. 42, 2000 - WIPO
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>42</strong>/<strong>2000</strong><br />
15160 <strong>PCT</strong> <strong>Gazette</strong> - Section I - <strong>Gazette</strong> du <strong>PCT</strong> 19 Oct/oct <strong>2000</strong><br />
(74) TAKAHASHI, Shuichi et al. / etc.; Osaka<br />
Plant of Takeda Chemical Industries, Ltd.,<br />
17–85, Jusohonmachi 2–chome, Yodogawa–ku,<br />
Osaka–shi, Osaka 532–0024 (JP).<br />
(81) AE AG AL AM AU AZ BA BB BG BR BY<br />
CA CN CR CU CZ DM DZ EE GD GE HR<br />
HU ID IL IN IS JP KG KR KZ LC LK LR<br />
LT LV MA MD MG MK MN MX NO NZ<br />
PL RO RU SG SI SK TJ TM TR TT UA US<br />
UZ VN YU ZA; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 A61K 31/70, 48/00, A01N 43/04, C07H<br />
21/02, 21/04, C12Q 1/68, C12N 15/85,<br />
15/86<br />
(11) WO 00/61150 (13) A1<br />
(21) <strong>PCT</strong>/US00/09540<br />
(22) 10 Apr/avr <strong>2000</strong> (10.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 09/290,640 12 Apr/avr 1999<br />
(12.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
US<br />
(54) ANTISENSE MODULATION OF FAS<br />
MEDIATED SIGNALING<br />
MODULATION ANTISENS DE LA<br />
TRANSDUCTION DE SIGNAUX IN-<br />
DUITE PAR FAS<br />
(71) ISIS PHARMACEUTICALS, INC.<br />
[US/US]; 2292 Faraday Avenue, Carlsbad,<br />
CA 92008 (US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) DEAN, Nicholas, M. [GB/US]; 2110<br />
Whisperwind Lane, Olivenheim, CA 92024<br />
(US). MARCUSSON, Eric, G. [US/US];<br />
6369 Caminito de Pastel, San Diego, CA<br />
92111 (US).<br />
(74) LICATA, Jane, Massey et al. / etc.; Law<br />
Offices of Jane Massey Licata, 66 E. Main<br />
Street, Marlton, NJ 08053 (US).<br />
(81) AE AL AM AT AU AZ BA BB BG BR BY<br />
CA CH CN CR CU CZ DE DK DM EE ES<br />
FI GB GD GE GH GM HR HU ID IL IN<br />
IS JP KE KG KP KR KZ LC LK LR LS LT<br />
LU LV MA MD MG MK MN MW MX NO<br />
NZ PL PT RO RU SD SE SG SI SK SL TJ<br />
TM TR TT TZ UA UG US UZ VN YU ZA<br />
ZW; AP (GH GM KE LS MW SD SL SZ<br />
TZ UG ZW); EA (AM AZ BY KG KZ MD<br />
RU TJ TM); EP (AT BE CH CY DE DK ES<br />
FI FR GB GR IE IT LU MC NL PT SE);<br />
OA (BF BJ CF CG CI CM GA GN GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 31/70, 39/39, C07H 21/00<br />
(11) WO 00/61151 (13) A2<br />
(21) <strong>PCT</strong>/US00/09839<br />
(22) 12 Apr/avr <strong>2000</strong> (12.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 60/128,898 12 Apr/avr 1999<br />
(12.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
US<br />
(54) OLIGODEOXYNUCLEOTIDE AND ITS<br />
USE TO INDUCE AN IMMUNE RES-<br />
PONSE<br />
UN OLIGODESOXYNUCLEOTIDE ET<br />
SON EMPLOI POUR INDUIRE UNE<br />
REPONSE IMMUNITAIRE<br />
(71) THE GOVERNMENT OF THE UNITED<br />
STATES OF AMERICA, represented by<br />
THE SECRETARY, DEPARTMENT OF<br />
HEALTH AND HUMAN SERVICES<br />
[US/US]; National Institutes of Health Office<br />
of Technology Transfer, 6011 Executive<br />
Boulevard, Suite 325, Rockville, MD 20852<br />
(US).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) KLINMAN, Dennis [US/US]; 2 Candlelight<br />
Court, Potomac, MD 20854 (US).<br />
ISHII, Ken [JP/US]; 257 Congressional<br />
Lane #120, Rockville, DM 20852 (US).<br />
VERTHELYI, Daniela [AR/US]; 11615<br />
Regency Drive, Potomac, MD 20854 (US).<br />
(74) GAGALA, Bruce, M. et al. / etc.; Leydig,<br />
Voit & Mayer, Ltd., Suite 4900, Two Prudential<br />
Plaza, 180 <strong>No</strong>rth Stetson, Chicago,<br />
IL 60601–6780 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
(51) 7 A61K 31/70<strong>42</strong>, A61P 23/02, 29/00<br />
(11) WO 00/61152 (13) A1<br />
(21) <strong>PCT</strong>/SE00/00620<br />
(22) 30 Mar/mar <strong>2000</strong> (30.03.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) 9901257–7 9 Apr/avr 1999<br />
(09.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
SE<br />
(54) MANAGEMENT<br />
JOINT SURGERY<br />
OF PAIN AFTER<br />
CONTROLE DE LA DOULEUR EN<br />
CHIRURGIE DES ARTICULATIONS<br />
(71) HEL AB [SE/SE]; Hedner, Thomas, Intorp,<br />
S–520 10 Gällstad (SE).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) HEDNER, Thomas [SE/SE]; Intorp,<br />
S–520 10 Gällstad (SE). KARLSSON, Jon<br />
[SE/SE]; Ljunglidsvägen 5, S–448 31 Floda<br />
(SE). BRANDSSON, Sveinbjörn [IS/SE];<br />
Lövkullavägen 13, S–433 60 Sävedalen (SE).<br />
(74) CONIMAR AB; P.O. Box 2086, S–141 02<br />
Huddinge (SE).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
(51) 7 A61K 31/706, A61P 17/12, 35/00, 31/00<br />
(11) WO 00/61153 (13) A1<br />
(21) <strong>PCT</strong>/AU00/00300<br />
(22) 10 Apr/avr <strong>2000</strong> (10.04.<strong>2000</strong>)<br />
(25) en (26) en<br />
(30) PP 9686 9 Apr/avr 1999<br />
(09.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
AU<br />
(54) MEDICINAL COMPOSITIONS AND<br />
THEIR METHOD OF PREPARATION<br />
COMPOSITIONS MEDICINALES ET<br />
LEUR PROCEDE DE PREPARATION<br />
(71) CURA NOMINEES PTY. LTD. [AU/AU];<br />
772 Upper Brookfield Road, Upper Brookfield,<br />
QLD 4069 (AU).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) CHAM, Bill, E. [NL/AU]; 353 Woodlands<br />
Drive, Sheldon, QLD 4157 (AU).<br />
(74) CULLEN & CO.; Level 26, 239 George<br />
Street, Brisbane, QLD 4000 (AU).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY CA CH CN CR CU CZ DE DK DM DZ<br />
EE ES FI GB GD GE GH GM HR HU ID<br />
IL IN IS JP KE KG KP KR KZ LC LK LR<br />
LS LT LU LV MA MD MG MK MN MW<br />
MX NO NZ PL PT RO RU SD SE SG SI<br />
SK SL TJ TM TR TT TZ UA UG US UZ<br />
VN YU ZA ZW; AP (GH GM KE LS MW<br />
SD SL SZ TZ UG ZW); EA (AM AZ BY<br />
KG KZ MD RU TJ TM); EP (AT BE CH<br />
CY DE DK ES FI FR GB GR IE IT LU MC<br />
NL PT SE); OA (BF BJ CF CG CI CM GA<br />
GN GW ML MR NE SN TD TG).<br />
(51) 7 A61K 33/04<br />
(11) WO 00/61154 (13) A1<br />
(21) <strong>PCT</strong>/CA99/00892<br />
(22) 27 Sep/sep 1999 (27.09.1999)<br />
(25) en (26) en<br />
(30) 2,265,926 8 Apr/avr 1999<br />
(08.04.1999)<br />
(30) 60/128,360 8 Apr/avr 1999<br />
(08.04.1999)<br />
(43) 19 Oct/oct <strong>2000</strong> (19.10.<strong>2000</strong>)<br />
CA<br />
US<br />
(54) COMPOSITION, CONTAINING SU-<br />
BLIMED SULPHUR, FOR ALTERING<br />
PLASMA HOMODYST(E) LEVELS IN<br />
HUMANS